In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra

Int J Antimicrob Agents. 2019 Jul;54(1):95-98. doi: 10.1016/j.ijantimicag.2019.05.006. Epub 2019 May 7.

Abstract

The in vitro susceptibility of molecularly identified Hortaea werneckii isolates (n = 37), the causative agent of tinea nigra, originating from clinical and environmental sources was determined for nine antifungal agents. Posaconazole had the lowest geometric mean minimum inhibitory concentration (GM MIC) (0.07 µg/mL), followed by voriconazole (0.13 µg/mL), isavuconazole (0.14 µg/mL), itraconazole (0.16 µg/mL), terbinafine (0.19 µg/mL) and amphotericin B (0.92 µg/mL). In contrast, fluconazole (14.56 µg/mL), caspofungin (2.41 µg/mL) and anidulafungin (1.42 µg/mL) demonstrated the highest GM MICs/MECs against H. werneckii.

Keywords: Hortaea werneckii; In vitro susceptibility; Isavuconazole; Tinea nigra.

MeSH terms

  • Antifungal Agents / pharmacology*
  • Ascomycota / drug effects*
  • Ascomycota / isolation & purification
  • Environmental Microbiology*
  • Humans
  • Microbial Sensitivity Tests
  • Tinea / microbiology*

Substances

  • Antifungal Agents